ZIOPTAN is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Akorn, Inc.. The primary component is Tafluprost.
Product ID | 17478-609_01a2a304-9308-44dd-9c0f-db4d24757f5b |
NDC | 17478-609 |
Product Type | Human Prescription Drug |
Proprietary Name | ZIOPTAN |
Generic Name | Tafluprost |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2014-11-26 |
Marketing Category | NDA / NDA |
Application Number | NDA202514 |
Labeler Name | Akorn, Inc. |
Substance Name | TAFLUPROST |
Active Ingredient Strength | 0 mg/.3mL |
Pharm Classes | Prostaglandin Analog [EPC],Prostaglandin Receptor Agonists [MoA],Increased Prostaglandin Activity [PE],Prostaglandins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2017-11-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA202514 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-11-26 |
Marketing Category | NDA |
Application Number | NDA202514 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-11-26 |
Marketing Category | NDA |
Application Number | NDA202514 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-11-26 |
Marketing Category | NDA |
Application Number | NDA202514 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-11-26 |
Ingredient | Strength |
---|---|
TAFLUPROST | .0045 mg/.3mL |
SPL SET ID: | a3173c26-0e19-47af-a01c-3fc06b2700d1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
17478-609 | ZIOPTAN | tafluprost |
82584-609 | ZIOPTAN | Tafluprost |
0781-6184 | Tafluprost | Tafluprost |
65302-062 | Tafluprost | Tafluprost |
66993-429 | Tafluprost Ophthalmic | tafluprost |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZIOPTAN 85091319 4161745 Live/Registered |
Merck Sharp & Dohme Corp. 2010-07-23 |